Do We Have a Winner? Advocating for SBRT in HCC Management
Open Access
- 2 February 2024
- journal article
- editorial
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 45, 100740
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Local Control After Stereotactic Body Radiation Therapy for Liver TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
- Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialThe Lancet Oncology, 2017
- A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) with DEBDOX beads as a bridge to transplant in hepatocellular carcinoma (HCC).Journal of Clinical Oncology, 2017
- Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular CarcinomaJournal of Clinical Oncology, 2016
- Effect of heat sink on the recurrence of small malignant hepatic tumors after radiofrequency ablationJournal of Cancer Research and Therapeutics, 2016
- Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinomaHistopathology, 2014
- Dose-Escalation Study of Single-Fraction Stereotactic Body Radiotherapy for Liver MalignanciesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiofrequency Ablation of Hepatocellular Carcinoma: Pros and ConsGut and Liver, 2010